Advertisement

Research Article Free access | 10.1172/JCI115604

"Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.

D T Hung, T K Vu, V I Wheaton, I F Charo, N A Nelken, N Esmon, C T Esmon, and S R Coughlin

Department of Medicine, University of California, San Francisco 94143.

Find articles by Hung, D. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco 94143.

Find articles by Vu, T. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco 94143.

Find articles by Wheaton, V. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco 94143.

Find articles by Charo, I. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco 94143.

Find articles by Nelken, N. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco 94143.

Find articles by Esmon, N. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco 94143.

Find articles by Esmon, C. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco 94143.

Find articles by Coughlin, S. in: JCI | PubMed | Google Scholar

Published February 1, 1992 - More info

Published in Volume 89, Issue 2 on February 1, 1992
J Clin Invest. 1992;89(2):444–450. https://doi.org/10.1172/JCI115604.
© 1992 The American Society for Clinical Investigation
Published February 1, 1992 - Version history
View PDF
Abstract

Platelet activation by thrombin plays a critical role in hemostasis and thrombosis. Based on structure-activity studies of a cloned platelet thrombin receptor, we designed two "mirror image" antagonists of thrombin and thrombin receptor function. First, "uncleavable" peptides mimicking the receptor domain postulated to interact with thrombin were found to be potent thrombin inhibitors. Second, proteolytically inactive mutant thrombins designed to bind but not cleave the thrombin receptor were found to be specific antagonists of receptor activation by thrombin. The effectiveness of these designed antagonists in blocking thrombin-induced platelet activation suggests a model for thrombin-receptor interaction and possible strategies for the development of novel antithrombotic agents.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (February 1, 1992): No description
Advertisement
Advertisement